Literature DB >> 33128600

Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.

Lin Yan1,2, Yukun Luo3, Jing Xiao1, Lin Lin1.   

Abstract

OBJECTIVE: To investigate the intra- and inter-observer reliability and agreement between gray-scale and Doppler ultrasound (US) and contrast-enhanced ultrasound (CEUS) in measuring ablated volume (Va) after radiofrequency ablation (RFA) for benign thyroid nodules.
METHODS: A total of 173 patients with 190 benign thyroid nodules who underwent RFA were included in this study. After RFA, the total volume of ablated nodule was divided into Va and the incompletely treated vital volume. Patients were followed up at 1, 3, 6, 12 months, and every 12 months thereafter. Two independent observers measured Va using US and CEUS during the same follow-up visit. The intra- and inter-observer reliability of the two measurement modalities was assessed using intraclass correlation coefficient (ICC) with 95% confidence interval. The Bland-Altman analysis was used to evaluate agreement, which was expressed as a mean difference with 95% limits of agreement (LOA).
RESULTS: The mean follow-up time was 23.17 ± 12.70 months. Va measured by US was significantly larger than by CEUS (p < 0.001). The intra- and inter-observer reliability decreased over the follow-up period and became moderate in both subgroups at 12 months (all ICC < 0.75). The mean difference and LOA became larger and wider during the follow-up. The best agreement was found in nodules < 10 ml at 1 month with a mean difference of 1.166 and LOA between 0.413 and 3.294.
CONCLUSIONS: The intra- and inter-observer reliability and agreement of US and CEUS in measuring Va were unsatisfactory. CEUS should be considered when Va was needed for further evaluation or in the case of nodules with suspected regrowth. KEY POINTS: • Va measured by gray-scale and Doppler US was significantly larger than that by CEUS. • Va measured by gray-scale and Doppler US lacked intra- and inter-observer reliability and agreement with CEUS. • CEUS should be preceded to gray-scale and Doppler US for the measurement of Va.

Entities:  

Keywords:  Radiofrequency ablation; Reproducibility of results; Thyroid nodule; Ultrasonography

Year:  2020        PMID: 33128600     DOI: 10.1007/s00330-020-07398-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  39 in total

1.  Efficacy and Safety of Radiofrequency Ablation Versus Observation for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial.

Authors:  Maurilio Deandrea; Jin Yong Sung; Paolo Limone; Alberto Mormile; Francesca Garino; Federico Ragazzoni; Kyu Sun Kim; Ducky Lee; Jung Hwan Baek
Journal:  Thyroid       Date:  2015-07-13       Impact factor: 6.568

2.  Treatment of thyroid nodules with radiofrequency: a 1-year follow-up experience.

Authors:  Paolo Rabuffi; Antonio Spada; Daniela Bosco; Antonio Bruni; Simone Vagnarelli; Cesare Ambrogi; Enrico Di Stasio; Assunta Santonati
Journal:  J Ultrasound       Date:  2019-04-03

3.  Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume.

Authors:  Jung Suk Sim; Jung Hwan Baek; Joongyub Lee; Woojin Cho; Sung Il Jung
Journal:  Int J Hyperthermia       Date:  2017-04-10       Impact factor: 3.914

Review 4.  Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis.

Authors:  Sae Rom Chung; Chong Hyun Suh; Jung Hwan Baek; Hye Sun Park; Young Jun Choi; Jeong Hyun Lee
Journal:  Int J Hyperthermia       Date:  2017-06-26       Impact factor: 3.914

Review 5.  Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment.

Authors:  Maija Radzina; Vito Cantisani; Madara Rauda; Michael Bachmann Nielsen; Caroline Ewertsen; Ferdinando D'Ambrosio; Peteris Prieditis; Salvatore Sorrenti
Journal:  Int J Surg       Date:  2017-05       Impact factor: 6.071

6.  Outcomes of Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules: A Mayo Clinic Case Series.

Authors:  Oksana Hamidi; Matthew R Callstrom; Robert A Lee; Diana Dean; M Regina Castro; John C Morris; Marius N Stan
Journal:  Mayo Clin Proc       Date:  2018-03-21       Impact factor: 7.616

7.  Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules.

Authors:  Roberto Cesareo; Valerio Pasqualini; Carla Simeoni; Marco Sacchi; Erminio Saralli; Giuseppe Campagna; Roberto Cianni
Journal:  J Clin Endocrinol Metab       Date:  2014-11-11       Impact factor: 5.958

8.  US-Guided Percutaneous Radiofrequency versus Microwave Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study.

Authors:  Zhigang Cheng; Ying Che; Songyuan Yu; Shurong Wang; Dengke Teng; Huixiong Xu; Jianwei Li; Desheng Sun; Zhiyu Han; Ping Liang
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

9.  Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up.

Authors:  Yang Guang; Wen He; Yukun Luo; Hongxia Zhang; Yukang Zhang; Bin Ning; Tengfei Yu
Journal:  BMC Cancer       Date:  2019-02-13       Impact factor: 4.430

10.  2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology.

Authors:  Ji-Hoon Kim; Jung Hwan Baek; Hyun Kyung Lim; Hye Shin Ahn; Seon Mi Baek; Yoon Jung Choi; Young Jun Choi; Sae Rom Chung; Eun Ju Ha; Soo Yeon Hahn; So Lyung Jung; Dae Sik Kim; Soo Jin Kim; Yeo Koon Kim; Chang Yoon Lee; Jeong Hyun Lee; Kwang Hwi Lee; Young Hen Lee; Jeong Seon Park; Hyesun Park; Jung Hee Shin; Chong Hyun Suh; Jin Yong Sung; Jung Suk Sim; Inyoung Youn; Miyoung Choi; Dong Gyu Na
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

View more
  5 in total

1.  A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.

Authors:  Yaqiong Zhu; Ziyu Jiao; Lianhua Zhu; Fang Xie; Qing Song; Lin Yan; Yukun Luo; Mingbo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

2.  Contrast-enhanced ultrasound improves the potency of fine-needle aspiration in thyroid nodules with high inadequate risk.

Authors:  Tinghui Yin; Bowen Zheng; Yufan Lian; Haifeng Li; Lei Tan; Shicheng Xu; Yong Liu; Tao Wu; Jie Ren
Journal:  BMC Med Imaging       Date:  2022-05-02       Impact factor: 2.795

3.  Automatic quantitative evaluation of normal pancreas based on deep learning in a Chinese adult population.

Authors:  Jinxiu Cai; Xiaochao Guo; Ke Wang; Yaofeng Zhang; Dadou Zhang; Xiaodong Zhang; Xiaoying Wang
Journal:  Abdom Radiol (NY)       Date:  2022-01-22

4.  Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study.

Authors:  Yu Lan; Nan Li; Qing Song; Ming-Bo Zhang; Yu-Kun Luo; Yan Zhang
Journal:  BMC Med Imaging       Date:  2021-11-22       Impact factor: 1.930

5.  A Review of Imaging Methods to Assess Ultrasound-Mediated Ablation.

Authors:  Brett Z Fite; James Wang; Pejman Ghanouni; Katherine W Ferrara
Journal:  BME Front       Date:  2022-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.